| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | See Remark | SVP And General Counsel +1 more
2 companies
Matsuda Masaru is a See Remarks at Arcutis Biotherapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $4.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 8,338 | $12.70 | $105,892.60 | -4.5% | +21.4% | +106.4% | |
| Nov 30, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Buy | 5,657 | $3.28 | $18,542.64 | +1.5% | +5.0% | +132.9% | |
| Nov 19, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,775 | $9.68 | $17,190.34 | -1.0% | +24.0% | +176.4% | |
| Nov 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 5,015 | $8.68 | $43,551.26 | -2.7% | +45.5% | +175.3% | |
| Aug 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 5,220 | $9.02 | $47,064.04 | -2.8% | -10.2% | +54.5% | |
| May 28, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remark | Sell | 1,775 | $9.01 | $15,988.14 | -0.9% | +19.1% | +52.9% | |
| May 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remark | Sell | 5,016 | $8.74 | $43,828.80 | -2.6% | +17.1% | +77.2% | |
| Mar 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remark | Sell | 3,760 | $11.12 | $41,815.71 | -1.9% | -25.4% | +22.4% | |
| Nov 21, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remark | Sell | 1,850 | $1.98 | $3,661.15 | -3.8% | +401.6% | +438.6% | |
| May 31, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remark | Sell | 1,830 | $7.80 | $14,278.21 | -4.2% | +16.4% | +15.3% |